RELAXO.NSRELAXO.NSNSE
Loading
EBITDA Over TimeStable
Percentile Rank71
3Y CAGR-2.5%
5Y CAGR-0.4%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
-2.5%/yr
vs +9.6%/yr prior
5Y CAGR
-0.4%/yr
Consistent
Acceleration
-12.1pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineStable
PeriodValueYoY Change
2025$4.09B-6.6%
2024$4.38B+22.7%
2023$3.57B-19.2%
2022$4.41B-15.1%
2021$5.20B+24.4%
2020$4.18B+23.9%
2019$3.37B+10.1%
2018$3.06B+25.5%
2017$2.44B-1.4%
2016$2.47B-